Mealey's (June 22, 2021, 1:07 PM EDT) -- WASHINGTON, D.C. — The Federal Circuit U.S. Court of Appeals on June 21 denied a petition for rehearing of a recent ruling that confirmed as invalid for lack of enablement two patents relating to antibodies that lower cholesterol....